AGP Picks
View all

Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on June 18, 2026

Certrec Expands Fatigue Rule Management System with Automated Workforce Management Capabilities
The Hidden Financial System Behind Pipelines, Ports, and Power Projects
Third Coast Expands Customer Acquisition Campaigns Through Direct Marketing in Texas Markets
XPerf ClusterReady™ Validates AI Racks 10× Faster: Delivers Industry-Leading AMD GPU Cluster Results with MiTAC Computing
ReelGOLF® and ShotReel Partner to Bring PGA-Tour Level Video Experiences to Amateur Golf Events in Arizona
Money Simpler Launches Multi-Strategy AI Quantitative Trading Platform for Digital Asset Investors
Hi*Ball Energy erobert Großbritannien und wird zum Vorreiter des neuen „Clean Energy“-Trends
Hi*Ball Energy fait son entrée au Royaume-Uni et redéfinit les codes de la boisson énergisante
C1 Announces Enterprise-Managed Authorization Support to Drive Secure AI Transformation for the Enterprise
Teva Releases Q2 2026 Aide Memoire
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
JellyFil Supplement Claims Evaluated: Documenting Jelly Fil Gummies Ingredients Investigation for Consumer Safety
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Odysight.ai® Clarifies its Disciplined Approach to Capital Raising
BlockchAIn Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases 
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
Constantiam Biosciences and Cincinnati Children’s Collaborate to Accelerate First-in-Class Neuronopathic Gaucher Disease Therapies

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Texas Technology Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.